| Sep 5 |
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
|
| Aug 30 |
TG Therapeutics Inc (NASDAQ:TGTX) A Bull Case Theory
|
| Aug 30 |
TG Therapeutics: Outpacing Skeptics With Briumvi's Growth Surge (Rating Upgrade)
|
| Aug 23 |
High Growth Tech Stocks in the United States to Watch
|
| Aug 19 |
IBD 50 Stock TG Therapeutics Breaks Out Bullishly After 'Solid' Quarter
|
| Aug 19 |
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
|
| Aug 16 |
IBD Stock Of The Day TG Therapeutics Flirts With Two Breakouts On Its Newfound Profitability
|
| Aug 12 |
FDA grants IND clearance for TG Therapeutics’ trial of multiple sclerosis treatment
|
| Aug 9 |
Results: TG Therapeutics, Inc. Confounded Analyst Expectations With A Surprise Profit
|
| Aug 7 |
TG Therapeutics Delivers A Beat-And-Raise Q2 And A $100 Million Buyback
|
